• ქართული
  • English
  • Novartis sells stake in venture to GSK for $13 billion

    ZURICH (Reuters) – Novartis will sell its 36.5 percent stake in a consumer healthcare joint venture to GSK for $13.0 billion in cash to focus on strategic priorities, the Swiss drugmaker said on Tuesday.

    Market Quotes by TradingView